Compare Phillips 66 (PSX) vs Revolution Medicines Inc. Common Stock (RVMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Phillips 66 vs Revolution Medicines Inc. Common Stock — how do they compare? Phillips 66 trades at $278.18 (market cap $112.36B), while Revolution Medicines Inc. Common Stock trades at $189.76 (market cap $40.32B). The key difference: Phillips 66 is far larger — about 2.8× Revolution Medicines Inc. Common Stock's market cap, and Phillips 66 pays a 1.8% dividend while Revolution Medicines Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Phillips 66 for 62 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| PSX | RVMD | |
|---|---|---|
Market Cap | $112.36B | $40.32B |
Volume | 2,374,751 | 4,855,734 |
Sector | Energy | Health |
52-Week High | $281.60 | $221.15 |
52-Week Low | $126.76 | $47.50 |
Typical Hold Time | 62 Days | 0 Days |
Enterprise Value | $128.83B | $37.02B |
Dividend Yield | 1.8% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Phillips 66 (PSX) trades at $281.60, up 3.67% over the past 24 hours and near its 52-week high, supported by bullish technical indicators and strong earnings beats in recent quarters. The company's fundamentals show solid profitability with a 4.66% net income margin and 24.02% ROE, while valuation ratios like a P/E of 16.07 and P/S of 0.75 appear reasonable. Recent news highlights structural strength in refining margins and AI-driven operational improvements.
The outlook for PSX is positive, driven by elevated refining crack spreads and debt-reduction progress, but risks include volatile energy prices and potential policy impacts on diesel exports. Analyst consensus leans bullish with a $279 price target, offering moderate upside from current levels amid robust institutional sentiment.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Phillips 66
Phillips 66 is an independent refiner with 12 refineries that have a total crude throughput capacity of 2.0 million barrels per day, or mmb/d, after converting its 255 mb/d Alliance refinery to a terminal. The midstream segment comprises extensive transportation and NGL processing assets. It also includes its DCP Midstream joint venture, which holds 45 natural gas processing facilities, 11 NGL fractionation plants, and a natural gas pipeline system with 58,000 miles of pipeline. Its CPChem chemical joint venture operates facilities in the United States and the Middle East and primarily produces olefins and polyolefins.
Read more on PSX →About Revolution Medicines Inc. Common Stock
Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →
